Deep Track Capital, LP
Top Portfolio Positions
62 positions ·
$4,846,263,139 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
3,338,241 | $308,353,321 | 6.36% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
11,526,971 | $286,329,959 | 5.91% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
3,600,000 | $252,540,000 | 5.21% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
4,300,000 | $249,873,000 | 5.16% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
4,279,848 | $206,288,673 | 4.26% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
1,100,000 | $185,922,000 | 3.84% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
4,532,374 | $182,337,406 | 3.76% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
19,686,282 | $166,742,808 | 3.44% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
4,106,067 | $165,187,075 | 3.41% | |
| ALMS |
Alumis Inc.
Healthcare
|
6,772,595 | $149,200,267 | 3.08% |
Portfolio Trend
22 quarters · across all stocks
Holdings in ALGS
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,299,737 | 444,110 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,139,105 | 444,110 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,352,278 | 444,110 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,202,033 | 444,110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,663,907 | 444,110 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,725,342 | 244,110 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,113,992 | 244,110 | Shares | Sole | 2024-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||